Skip to main content

ADEISS

ServiceLondon, Ontario, CanadaFounded 2016· One of 1986 Service companies tracked by AMPulse

Designs, develops, and delivers precise titanium-based 3D-printed medical implants, prototypes, and surgical tools using additive manufacturing, reducing patient costs and improving surgical outcomes.

CEO / Founder
Paul Paolatto
Team Size
11-50
Stage
Active
Total Funding
$6.8M
Latest Round
Grant
Key Investors
Western University; Renishaw; London Medical Network

Technology & Products

Key Products

Titanium-based 3D-printed implants; Surgical tools; Medical device prototypes; Patient-specific cranial plates; Spinal implant systems (e.g., DC2 system)

Technological Advantage

Access to Renishaw's high-precision metal 3D printing technology (e.g., Renishaw AM 400) and ISO 13485 compliance, enabling rapid prototyping and production of custom medical devices with reduced lead times and costs.

Differentiation

Value Proposition

Provides ISO 13485 compliant, biocompatible 3D-printed medical devices that reduce overall costs to patients and healthcare systems while enabling faster, more precise surgical solutions.

How They Differentiate

Focuses exclusively on metal 3D printing (titanium) for medical implants and tools within a dedicated ISO 13485 facility, unlike broader AM service bureaus; leverages direct partnerships with healthcare providers and Renishaw's technology for precision and compliance.

Market & Competition

Target Customers

Medical practitioners, researchers, and medical device companies requiring custom, patient-specific implants and surgical tools.

Industry Verticals

Medical Devices; Healthcare; Dental; Orthopedics

Competitors

Materialise; 3D Systems Healthcare; Stratasys Medical; EOS Medical Solutions

Growth & Milestones

Growth Metrics

Creates direct employment for approximately 20 knowledge workers; part of a broader $10 million investment by the City of London in the London Medical Network.

Major Milestones

Founded in 2017 through a $6.8 million partnership; Established as Canada's first medical/dental device AM R&D centre; ISO 13485 compliance achieved; Partnership with Renishaw for AM technology platforms

Notable Customers

A-Line Orthopaedics (for DC2 spinal implant system)

https://adeiss.ca

Why this company matters

ADEISS operates as a dedicated metal additive manufacturing service bureau for medical devices, differentiating itself from broader AM service providers by focusing exclusively on titanium PBF-LB within an ISO 13485-certified facility. Founded through a $6.8 million partnership among Western University, the London Medical Network, and Renishaw, the company was established as Canada's first medical and dental device research, development, and commercialization centre built around 3D printing.

The company's core technology relies on Renishaw's AM 400 system for high-precision laser powder bed fusion of titanium alloys. ADEISS produces patient-specific cranial plates, spinal implant systems such as the DC2 system developed with A-Line Orthopaedics, surgical tools, and medical device prototypes. The ISO 13485 quality management system enables the company to deliver biocompatible implants that reduce lead times and overall costs for healthcare systems.

Target customers include medical practitioners, researchers, and medical device companies requiring custom, patient-specific metal implants and instruments. ADEISS competes in a niche between large AM service bureaus like Materialise and 3D Systems Healthcare and in-house hospital 3D printing labs, leveraging direct partnerships with Renishaw, Robarts Research Institute, Lawson Health Research Institute, and St. Joseph's Health Care London to maintain clinical relevance and regulatory compliance.

The company's strategic moat lies in its exclusive focus on titanium medical devices combined with its tripartite governance structure linking academia, healthcare networks, and industrial AM expertise. A key open question is whether the company can scale beyond its current employment base of approximately 20 knowledge workers and expand its customer base beyond the initial spinal and cranial applications into higher-volume orthopedic segments.